Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosome Deletion | 62 | 2019 | 1005 | 5.550 |
Why?
|
Comparative Genomic Hybridization | 74 | 2020 | 691 | 5.080 |
Why?
|
Chromosome Aberrations | 57 | 2022 | 1960 | 4.970 |
Why?
|
Oligonucleotide Array Sequence Analysis | 49 | 2018 | 2508 | 3.830 |
Why?
|
Developmental Disabilities | 40 | 2018 | 674 | 3.470 |
Why?
|
Abnormalities, Multiple | 45 | 2018 | 998 | 3.430 |
Why?
|
Gene Duplication | 36 | 2016 | 421 | 3.340 |
Why?
|
DNA Copy Number Variations | 47 | 2020 | 1516 | 3.290 |
Why?
|
Chromosome Disorders | 31 | 2019 | 417 | 3.200 |
Why?
|
Mosaicism | 22 | 2022 | 272 | 2.900 |
Why?
|
Prenatal Diagnosis | 35 | 2021 | 590 | 2.640 |
Why?
|
In Situ Hybridization, Fluorescence | 68 | 2022 | 2232 | 2.410 |
Why?
|
Chromosome Duplication | 12 | 2017 | 157 | 2.290 |
Why?
|
Intellectual Disability | 37 | 2018 | 1032 | 2.270 |
Why?
|
Chromosomes, Human, X | 17 | 2019 | 192 | 2.260 |
Why?
|
Translocation, Genetic | 20 | 2022 | 1245 | 2.100 |
Why?
|
Nucleic Acid Hybridization | 21 | 2016 | 542 | 2.070 |
Why?
|
Gene Dosage | 31 | 2015 | 829 | 1.950 |
Why?
|
Phenotype | 52 | 2019 | 6295 | 1.640 |
Why?
|
Gene Rearrangement | 16 | 2020 | 783 | 1.600 |
Why?
|
Karyotyping | 38 | 2022 | 1022 | 1.570 |
Why?
|
Chromosomes, Human, Pair 15 | 13 | 2018 | 231 | 1.530 |
Why?
|
Exons | 13 | 2020 | 1328 | 1.500 |
Why?
|
Chromosomes, Human, Pair 14 | 8 | 2019 | 272 | 1.430 |
Why?
|
Genome, Human | 33 | 2020 | 1869 | 1.410 |
Why?
|
Gene Deletion | 17 | 2015 | 1442 | 1.400 |
Why?
|
Chromosomes, Human, Pair 17 | 14 | 2015 | 641 | 1.310 |
Why?
|
Chromosomes, Human, Pair 16 | 11 | 2018 | 254 | 1.300 |
Why?
|
Language Development Disorders | 12 | 2017 | 167 | 1.260 |
Why?
|
Sequence Deletion | 21 | 2018 | 875 | 1.190 |
Why?
|
Child, Preschool | 81 | 2019 | 16273 | 1.180 |
Why?
|
Chromosomes, Human, Pair 10 | 7 | 2016 | 135 | 1.160 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2014 | 96 | 1.040 |
Why?
|
Methyl-CpG-Binding Protein 2 | 7 | 2015 | 291 | 1.010 |
Why?
|
Sex Chromosome Aberrations | 8 | 2021 | 50 | 1.010 |
Why?
|
Microarray Analysis | 15 | 2020 | 392 | 0.990 |
Why?
|
Segmental Duplications, Genomic | 11 | 2015 | 83 | 0.980 |
Why?
|
Chromosomes, Human, Pair 1 | 11 | 2014 | 327 | 0.970 |
Why?
|
Infant | 63 | 2018 | 13310 | 0.960 |
Why?
|
Autistic Disorder | 11 | 2018 | 319 | 0.920 |
Why?
|
Microcephaly | 11 | 2018 | 325 | 0.910 |
Why?
|
Cytogenetic Analysis | 11 | 2017 | 568 | 0.890 |
Why?
|
Syndrome | 22 | 2019 | 1351 | 0.890 |
Why?
|
Chromosome Inversion | 6 | 2020 | 182 | 0.880 |
Why?
|
Ring Chromosomes | 1 | 2022 | 15 | 0.880 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2015 | 259 | 0.820 |
Why?
|
Chromosome Mapping | 20 | 2020 | 1471 | 0.810 |
Why?
|
Nerve Tissue Proteins | 11 | 2018 | 1491 | 0.810 |
Why?
|
Child | 77 | 2020 | 29154 | 0.780 |
Why?
|
Humans | 242 | 2022 | 261506 | 0.780 |
Why?
|
X Chromosome Inactivation | 7 | 2019 | 73 | 0.780 |
Why?
|
Chromosomes, Human, Pair 6 | 3 | 2014 | 179 | 0.760 |
Why?
|
Telomere | 6 | 2013 | 505 | 0.760 |
Why?
|
Female | 174 | 2022 | 141928 | 0.750 |
Why?
|
Pregnancy | 48 | 2022 | 7573 | 0.750 |
Why?
|
Chromosomes, Human, Pair 11 | 5 | 2011 | 402 | 0.740 |
Why?
|
Chromosome Banding | 17 | 2014 | 256 | 0.720 |
Why?
|
Male | 147 | 2020 | 123000 | 0.720 |
Why?
|
Pedigree | 20 | 2020 | 1890 | 0.700 |
Why?
|
Trisomy | 7 | 2017 | 231 | 0.690 |
Why?
|
Chromosomes, Human, Pair 18 | 4 | 2014 | 181 | 0.670 |
Why?
|
Cell Adhesion Molecules, Neuronal | 3 | 2018 | 101 | 0.660 |
Why?
|
DNA | 12 | 2016 | 2693 | 0.660 |
Why?
|
Chromosome Breakage | 15 | 2011 | 226 | 0.650 |
Why?
|
Genomics | 11 | 2016 | 2738 | 0.650 |
Why?
|
Chromosomes, Human, Y | 4 | 2014 | 53 | 0.620 |
Why?
|
Pathology, Molecular | 1 | 2018 | 128 | 0.600 |
Why?
|
Chromosomes, Human, Pair 9 | 7 | 2012 | 290 | 0.570 |
Why?
|
Introns | 2 | 2015 | 432 | 0.560 |
Why?
|
WAGR Syndrome | 2 | 2006 | 10 | 0.550 |
Why?
|
DiGeorge Syndrome | 3 | 2012 | 77 | 0.550 |
Why?
|
Sex Chromosome Disorders | 2 | 2015 | 9 | 0.550 |
Why?
|
Chromosomal Proteins, Non-Histone | 5 | 2018 | 362 | 0.540 |
Why?
|
Diagnosis | 1 | 2016 | 34 | 0.540 |
Why?
|
Chromosomes, Human, Pair 4 | 3 | 2016 | 108 | 0.540 |
Why?
|
Cognition Disorders | 5 | 2013 | 786 | 0.540 |
Why?
|
Growth and Development | 1 | 2015 | 28 | 0.530 |
Why?
|
Hernia, Diaphragmatic | 5 | 2011 | 121 | 0.530 |
Why?
|
Aneuploidy | 8 | 2021 | 369 | 0.520 |
Why?
|
Mutagenesis, Insertional | 2 | 2020 | 218 | 0.520 |
Why?
|
Chromosomes, Human, Pair 3 | 4 | 2013 | 311 | 0.520 |
Why?
|
Amniotic Fluid | 10 | 2016 | 123 | 0.520 |
Why?
|
False Positive Reactions | 2 | 2015 | 355 | 0.510 |
Why?
|
Fetal Diseases | 4 | 2018 | 388 | 0.510 |
Why?
|
Genetic Testing | 7 | 2019 | 1589 | 0.500 |
Why?
|
Epilepsy | 9 | 2018 | 883 | 0.500 |
Why?
|
Mental Retardation, X-Linked | 3 | 2012 | 94 | 0.500 |
Why?
|
Craniofacial Abnormalities | 9 | 2013 | 239 | 0.500 |
Why?
|
Infant, Newborn | 26 | 2015 | 8223 | 0.500 |
Why?
|
Chromosomes, Human | 7 | 2020 | 295 | 0.490 |
Why?
|
Homeodomain Proteins | 7 | 2017 | 1143 | 0.490 |
Why?
|
Genetic Diseases, Inborn | 5 | 2017 | 442 | 0.490 |
Why?
|
Adolescent | 44 | 2018 | 31252 | 0.480 |
Why?
|
Rubinstein-Taybi Syndrome | 2 | 2010 | 16 | 0.470 |
Why?
|
Otx Transcription Factors | 2 | 2014 | 22 | 0.460 |
Why?
|
Chromosomes, Human, Pair 22 | 8 | 2017 | 169 | 0.460 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2019 | 4549 | 0.460 |
Why?
|
CREB-Binding Protein | 2 | 2010 | 86 | 0.460 |
Why?
|
Chorionic Villi | 5 | 2016 | 17 | 0.460 |
Why?
|
Chromosomes, Human, Pair 7 | 4 | 2010 | 234 | 0.460 |
Why?
|
Base Sequence | 22 | 2016 | 4917 | 0.450 |
Why?
|
Genetic Loci | 1 | 2015 | 481 | 0.440 |
Why?
|
Whole Genome Sequencing | 6 | 2020 | 338 | 0.440 |
Why?
|
Branchio-Oto-Renal Syndrome | 2 | 2010 | 11 | 0.430 |
Why?
|
Genome-Wide Association Study | 3 | 2018 | 2265 | 0.430 |
Why?
|
Genetic Counseling | 8 | 2018 | 380 | 0.430 |
Why?
|
Sequence Analysis, DNA | 17 | 2020 | 2483 | 0.430 |
Why?
|
Proteins | 4 | 2018 | 1963 | 0.430 |
Why?
|
Fragile X Mental Retardation Protein | 2 | 2012 | 126 | 0.420 |
Why?
|
Fetus | 6 | 2022 | 601 | 0.420 |
Why?
|
Heart Defects, Congenital | 8 | 2015 | 1697 | 0.420 |
Why?
|
Genomic Instability | 7 | 2017 | 519 | 0.410 |
Why?
|
Agenesis of Corpus Callosum | 1 | 2011 | 36 | 0.410 |
Why?
|
Face | 4 | 2018 | 273 | 0.400 |
Why?
|
Muscle Hypotonia | 5 | 2013 | 180 | 0.390 |
Why?
|
Chromosome Breakpoints | 8 | 2019 | 104 | 0.390 |
Why?
|
Isochromosomes | 1 | 2011 | 55 | 0.390 |
Why?
|
Gonadal Dysgenesis, Mixed | 1 | 2010 | 1 | 0.380 |
Why?
|
Recombination, Genetic | 4 | 2015 | 613 | 0.380 |
Why?
|
Genotype | 9 | 2016 | 4109 | 0.380 |
Why?
|
Mental Disorders | 7 | 2015 | 862 | 0.370 |
Why?
|
E1A-Associated p300 Protein | 1 | 2010 | 92 | 0.360 |
Why?
|
Chromosomes, Human, Pair 8 | 4 | 2022 | 317 | 0.360 |
Why?
|
Body Height | 2 | 2011 | 231 | 0.350 |
Why?
|
Amniocentesis | 8 | 2017 | 76 | 0.350 |
Why?
|
Facies | 9 | 2018 | 149 | 0.340 |
Why?
|
DNA Replication | 6 | 2019 | 744 | 0.340 |
Why?
|
Adult | 53 | 2019 | 77950 | 0.340 |
Why?
|
Goldenhar Syndrome | 1 | 2008 | 15 | 0.330 |
Why?
|
Williams Syndrome | 2 | 2012 | 37 | 0.330 |
Why?
|
Transcription Factors | 9 | 2018 | 5270 | 0.320 |
Why?
|
Homologous Recombination | 6 | 2020 | 185 | 0.320 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2017 | 1265 | 0.320 |
Why?
|
Molecular Sequence Data | 18 | 2016 | 6089 | 0.310 |
Why?
|
DNA Methylation | 7 | 2019 | 2669 | 0.310 |
Why?
|
Germ Cells | 3 | 2022 | 335 | 0.310 |
Why?
|
Trans-Activators | 4 | 2015 | 1555 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 9 | 2019 | 5539 | 0.310 |
Why?
|
Haploinsufficiency | 5 | 2017 | 294 | 0.310 |
Why?
|
Brain | 8 | 2015 | 4113 | 0.300 |
Why?
|
Nuclear Proteins | 7 | 2018 | 3343 | 0.300 |
Why?
|
Genetic Variation | 6 | 2013 | 2086 | 0.300 |
Why?
|
Hearing Loss | 1 | 2008 | 153 | 0.300 |
Why?
|
Membrane Proteins | 9 | 2018 | 2819 | 0.290 |
Why?
|
Point Mutation | 2 | 2009 | 769 | 0.290 |
Why?
|
Chorionic Villi Sampling | 5 | 2017 | 46 | 0.290 |
Why?
|
Genetic Association Studies | 6 | 2019 | 1084 | 0.290 |
Why?
|
Congenital Abnormalities | 4 | 2016 | 260 | 0.280 |
Why?
|
Chromosomes, Artificial, Bacterial | 6 | 2008 | 129 | 0.280 |
Why?
|
Chromosomes, Human, Pair 2 | 4 | 2014 | 172 | 0.280 |
Why?
|
Forkhead Transcription Factors | 4 | 2014 | 778 | 0.270 |
Why?
|
Monosomy | 1 | 2006 | 95 | 0.270 |
Why?
|
Blepharoptosis | 1 | 2006 | 70 | 0.270 |
Why?
|
Protein Array Analysis | 1 | 2008 | 501 | 0.270 |
Why?
|
Blastocyst | 1 | 2006 | 124 | 0.270 |
Why?
|
Quantitative Trait Loci | 1 | 2007 | 374 | 0.260 |
Why?
|
Genomic Imprinting | 3 | 2019 | 194 | 0.260 |
Why?
|
Child Behavior | 1 | 2007 | 243 | 0.260 |
Why?
|
Social Behavior | 1 | 2007 | 306 | 0.260 |
Why?
|
Polymerase Chain Reaction | 7 | 2020 | 3203 | 0.250 |
Why?
|
Seizures | 7 | 2016 | 989 | 0.250 |
Why?
|
Mutation | 14 | 2018 | 15179 | 0.250 |
Why?
|
Nuchal Translucency Measurement | 2 | 2022 | 25 | 0.250 |
Why?
|
Pregnancy Trimester, First | 4 | 2022 | 127 | 0.250 |
Why?
|
Carrier Proteins | 5 | 2018 | 2022 | 0.240 |
Why?
|
Models, Genetic | 7 | 2015 | 1113 | 0.240 |
Why?
|
DNA End-Joining Repair | 2 | 2020 | 86 | 0.230 |
Why?
|
Hernias, Diaphragmatic, Congenital | 5 | 2011 | 324 | 0.220 |
Why?
|
Cohort Studies | 13 | 2018 | 9244 | 0.220 |
Why?
|
INDEL Mutation | 2 | 2020 | 112 | 0.220 |
Why?
|
T-Box Domain Proteins | 2 | 2015 | 156 | 0.220 |
Why?
|
De Lange Syndrome | 3 | 2018 | 43 | 0.220 |
Why?
|
Chromosomes, Human, Pair 21 | 3 | 2008 | 104 | 0.220 |
Why?
|
Alleles | 5 | 2018 | 2437 | 0.220 |
Why?
|
Cell Cycle Proteins | 5 | 2018 | 2045 | 0.210 |
Why?
|
Chromosomes, Human, Pair 13 | 4 | 2014 | 141 | 0.210 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 2 | 2018 | 51 | 0.210 |
Why?
|
Endogenous Retroviruses | 2 | 2013 | 41 | 0.210 |
Why?
|
Diseases in Twins | 2 | 2016 | 99 | 0.210 |
Why?
|
Charcot-Marie-Tooth Disease | 3 | 2015 | 192 | 0.210 |
Why?
|
Genes, X-Linked | 3 | 2017 | 66 | 0.210 |
Why?
|
Young Adult | 18 | 2019 | 21445 | 0.210 |
Why?
|
Gene Order | 5 | 2013 | 111 | 0.210 |
Why?
|
Receptors, Cell Surface | 3 | 2012 | 862 | 0.200 |
Why?
|
Wolf-Hirschhorn Syndrome | 2 | 2018 | 7 | 0.200 |
Why?
|
Chromosomes | 2 | 2019 | 244 | 0.200 |
Why?
|
Pentobarbital | 1 | 2001 | 29 | 0.200 |
Why?
|
Exome | 4 | 2018 | 1239 | 0.200 |
Why?
|
Isoflurane | 1 | 2001 | 67 | 0.200 |
Why?
|
Anesthetics, Inhalation | 1 | 2001 | 62 | 0.190 |
Why?
|
alpha7 Nicotinic Acetylcholine Receptor | 4 | 2014 | 57 | 0.190 |
Why?
|
Auditory Cortex | 1 | 2001 | 38 | 0.190 |
Why?
|
Neurons, Afferent | 1 | 2001 | 122 | 0.190 |
Why?
|
Twins | 2 | 2000 | 70 | 0.190 |
Why?
|
Inheritance Patterns | 4 | 2020 | 139 | 0.180 |
Why?
|
Hydatidiform Mole | 1 | 2000 | 38 | 0.180 |
Why?
|
Fluorescent Dyes | 2 | 2016 | 459 | 0.180 |
Why?
|
Abortion, Habitual | 1 | 2019 | 24 | 0.180 |
Why?
|
DNA Repair | 3 | 2020 | 1872 | 0.180 |
Why?
|
Hypnotics and Sedatives | 1 | 2001 | 218 | 0.170 |
Why?
|
Quantitative Trait, Heritable | 1 | 2019 | 110 | 0.170 |
Why?
|
Hand Deformities, Congenital | 3 | 2018 | 87 | 0.170 |
Why?
|
Neural Cell Adhesion Molecules | 3 | 2018 | 55 | 0.170 |
Why?
|
Disease | 2 | 2012 | 165 | 0.170 |
Why?
|
Sensitivity and Specificity | 7 | 2009 | 4971 | 0.170 |
Why?
|
Antigens, Nuclear | 2 | 2018 | 119 | 0.170 |
Why?
|
Syndactyly | 2 | 2010 | 26 | 0.170 |
Why?
|
Biological Variation, Population | 1 | 2018 | 22 | 0.170 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2018 | 41 | 0.170 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 2019 | 362 | 0.160 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2018 | 28 | 0.160 |
Why?
|
Gametogenesis | 2 | 2017 | 28 | 0.160 |
Why?
|
Short Rib-Polydactyly Syndrome | 1 | 2018 | 2 | 0.160 |
Why?
|
Cytoplasmic Dyneins | 1 | 2018 | 7 | 0.160 |
Why?
|
Genetic Carrier Screening | 1 | 2018 | 92 | 0.160 |
Why?
|
Neurofibromatosis 1 | 1 | 1999 | 144 | 0.160 |
Why?
|
Ultrasonography, Prenatal | 4 | 2022 | 830 | 0.160 |
Why?
|
Polyhydramnios | 1 | 2018 | 36 | 0.160 |
Why?
|
Calcium-Binding Proteins | 4 | 2018 | 545 | 0.160 |
Why?
|
Embryonic Development | 2 | 2017 | 306 | 0.160 |
Why?
|
Turner Syndrome | 4 | 2017 | 68 | 0.160 |
Why?
|
Neurofibromatosis 2 | 1 | 2017 | 32 | 0.150 |
Why?
|
Genetic Markers | 5 | 2014 | 974 | 0.150 |
Why?
|
Anesthesia | 1 | 2001 | 296 | 0.150 |
Why?
|
Peptide Termination Factors | 1 | 2017 | 14 | 0.150 |
Why?
|
Down Syndrome | 3 | 2017 | 226 | 0.150 |
Why?
|
Cytoskeletal Proteins | 3 | 2018 | 492 | 0.150 |
Why?
|
Methyltransferases | 1 | 2018 | 148 | 0.150 |
Why?
|
Alu Elements | 2 | 2015 | 88 | 0.150 |
Why?
|
Prader-Willi Syndrome | 3 | 2017 | 69 | 0.150 |
Why?
|
Nervous System Diseases | 2 | 2019 | 500 | 0.150 |
Why?
|
Pelizaeus-Merzbacher Disease | 2 | 2006 | 20 | 0.140 |
Why?
|
Myelin Proteolipid Protein | 2 | 2006 | 25 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2020 | 2291 | 0.140 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2016 | 216 | 0.140 |
Why?
|
Microtubule-Associated Proteins | 4 | 2016 | 534 | 0.140 |
Why?
|
SOX9 Transcription Factor | 2 | 2015 | 170 | 0.140 |
Why?
|
Uniparental Disomy | 1 | 2016 | 66 | 0.140 |
Why?
|
Cardiovascular Abnormalities | 2 | 2014 | 54 | 0.140 |
Why?
|
Sex Chromosomes | 2 | 2021 | 43 | 0.140 |
Why?
|
Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 16 | 0.140 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 2390 | 0.140 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2015 | 8 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2008 | 332 | 0.130 |
Why?
|
Homozygote | 2 | 2019 | 717 | 0.130 |
Why?
|
Animals | 20 | 2018 | 59536 | 0.130 |
Why?
|
Maternal Age | 4 | 2014 | 152 | 0.130 |
Why?
|
Wounds, Stab | 1 | 2015 | 14 | 0.130 |
Why?
|
Myelin Proteins | 1 | 2015 | 90 | 0.130 |
Why?
|
Pierre Robin Syndrome | 1 | 2015 | 28 | 0.130 |
Why?
|
Spine | 3 | 2015 | 293 | 0.130 |
Why?
|
DNA-Binding Proteins | 5 | 2018 | 4821 | 0.130 |
Why?
|
Cell-Free Nucleic Acids | 1 | 2017 | 224 | 0.130 |
Why?
|
Catenins | 1 | 2015 | 51 | 0.130 |
Why?
|
Bone Diseases, Metabolic | 1 | 2015 | 84 | 0.130 |
Why?
|
Thoracic Injuries | 1 | 2015 | 58 | 0.130 |
Why?
|
Penetrance | 3 | 2011 | 126 | 0.130 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 1399 | 0.130 |
Why?
|
Multiple Trauma | 1 | 2015 | 64 | 0.120 |
Why?
|
R-SNARE Proteins | 1 | 2014 | 18 | 0.120 |
Why?
|
Mutation Rate | 2 | 2013 | 223 | 0.120 |
Why?
|
Vascular System Injuries | 1 | 2015 | 52 | 0.120 |
Why?
|
Cleft Palate | 1 | 2016 | 128 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2014 | 1439 | 0.120 |
Why?
|
Sex Characteristics | 3 | 2015 | 417 | 0.120 |
Why?
|
Urogenital System | 1 | 2014 | 59 | 0.120 |
Why?
|
Nails, Malformed | 1 | 2013 | 8 | 0.120 |
Why?
|
Benzoxazines | 1 | 2014 | 27 | 0.120 |
Why?
|
Polymorphism, Genetic | 3 | 2014 | 1450 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 6 | 2014 | 7702 | 0.120 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 78 | 0.120 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2014 | 61 | 0.120 |
Why?
|
Aging, Premature | 1 | 2013 | 38 | 0.120 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2013 | 33 | 0.110 |
Why?
|
Tetraspanins | 1 | 2013 | 42 | 0.110 |
Why?
|
Scoliosis | 1 | 2015 | 139 | 0.110 |
Why?
|
Parents | 2 | 2018 | 998 | 0.110 |
Why?
|
Leukoencephalopathies | 1 | 2013 | 63 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2013 | 143 | 0.110 |
Why?
|
Genotyping Techniques | 1 | 2013 | 166 | 0.110 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 2 | 2009 | 14 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2015 | 1498 | 0.110 |
Why?
|
Zebrafish | 4 | 2017 | 463 | 0.110 |
Why?
|
Microfilament Proteins | 2 | 2013 | 487 | 0.110 |
Why?
|
Genes, Recessive | 1 | 2013 | 200 | 0.110 |
Why?
|
Internationality | 1 | 2013 | 208 | 0.110 |
Why?
|
Fractures, Bone | 1 | 2015 | 291 | 0.110 |
Why?
|
Munc18 Proteins | 1 | 2012 | 39 | 0.110 |
Why?
|
Pregnancy Outcome | 2 | 2015 | 643 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 144 | 0.110 |
Why?
|
Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.100 |
Why?
|
Receptors, Nicotinic | 2 | 2010 | 190 | 0.100 |
Why?
|
Aortic Coarctation | 1 | 2013 | 103 | 0.100 |
Why?
|
Urogenital Abnormalities | 1 | 2014 | 174 | 0.100 |
Why?
|
Culture Techniques | 1 | 1991 | 132 | 0.100 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2009 | 98 | 0.100 |
Why?
|
Child Behavior Disorders | 1 | 2012 | 68 | 0.100 |
Why?
|
Hemophilia A | 1 | 2011 | 25 | 0.100 |
Why?
|
Autism Spectrum Disorder | 1 | 2017 | 363 | 0.100 |
Why?
|
X Chromosome | 3 | 2008 | 339 | 0.100 |
Why?
|
Evolution, Molecular | 2 | 2014 | 834 | 0.100 |
Why?
|
Preimplantation Diagnosis | 1 | 2012 | 47 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 854 | 0.100 |
Why?
|
Metaphase | 3 | 2008 | 107 | 0.100 |
Why?
|
Cell Line | 3 | 2014 | 5114 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2015 | 6150 | 0.100 |
Why?
|
Nerve Growth Factors | 1 | 2011 | 109 | 0.100 |
Why?
|
Fragile X Syndrome | 1 | 2012 | 150 | 0.100 |
Why?
|
Malformations of Cortical Development | 1 | 2011 | 57 | 0.100 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 343 | 0.100 |
Why?
|
Sexual Development | 1 | 2010 | 24 | 0.100 |
Why?
|
Receptors, Odorant | 1 | 2011 | 47 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 347 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 159 | 0.100 |
Why?
|
Molecular Chaperones | 1 | 2012 | 264 | 0.100 |
Why?
|
Horner Syndrome | 1 | 2010 | 12 | 0.100 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2010 | 11 | 0.100 |
Why?
|
Pseudogenes | 1 | 2011 | 81 | 0.100 |
Why?
|
MADS Domain Proteins | 1 | 2010 | 10 | 0.100 |
Why?
|
Organ Size | 1 | 2012 | 690 | 0.100 |
Why?
|
Lyases | 1 | 2010 | 10 | 0.100 |
Why?
|
Mothers | 1 | 2014 | 410 | 0.090 |
Why?
|
Myogenic Regulatory Factors | 1 | 2010 | 35 | 0.090 |
Why?
|
Cytogenetics | 2 | 2005 | 149 | 0.090 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2013 | 218 | 0.090 |
Why?
|
Endocrine System | 1 | 2010 | 36 | 0.090 |
Why?
|
Gene Frequency | 3 | 2020 | 1163 | 0.090 |
Why?
|
Repressor Proteins | 3 | 2010 | 1664 | 0.090 |
Why?
|
Spasms, Infantile | 1 | 2012 | 165 | 0.090 |
Why?
|
Cloaca | 1 | 2010 | 16 | 0.090 |
Why?
|
Anus, Imperforate | 1 | 2010 | 10 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 1506 | 0.090 |
Why?
|
Fetal Growth Retardation | 2 | 2016 | 194 | 0.090 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2012 | 461 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2020 | 37905 | 0.090 |
Why?
|
Estrogens | 1 | 2014 | 751 | 0.090 |
Why?
|
Cells, Cultured | 8 | 2015 | 5637 | 0.090 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2010 | 38 | 0.090 |
Why?
|
Oligospermia | 1 | 2010 | 67 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 546 | 0.090 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2010 | 182 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2013 | 376 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 589 | 0.090 |
Why?
|
Sodium Channels | 1 | 2010 | 109 | 0.090 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 43 | 0.090 |
Why?
|
PAX6 Transcription Factor | 2 | 2010 | 53 | 0.090 |
Why?
|
Family | 2 | 2011 | 736 | 0.090 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2011 | 229 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2016 | 6009 | 0.090 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 2195 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2012 | 842 | 0.090 |
Why?
|
Hernia, Umbilical | 1 | 2010 | 36 | 0.090 |
Why?
|
Azoospermia | 1 | 2010 | 45 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2010 | 220 | 0.090 |
Why?
|
Multigene Family | 1 | 2011 | 425 | 0.090 |
Why?
|
Age of Onset | 4 | 2013 | 827 | 0.090 |
Why?
|
Disease Management | 1 | 2015 | 1052 | 0.090 |
Why?
|
Mitochondrial Diseases | 1 | 2011 | 137 | 0.090 |
Why?
|
Paired Box Transcription Factors | 2 | 2010 | 134 | 0.090 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2008 | 9 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1046 | 0.080 |
Why?
|
Mitotic Index | 1 | 1989 | 162 | 0.080 |
Why?
|
Bayes Theorem | 1 | 2013 | 1021 | 0.080 |
Why?
|
HIV-1 | 1 | 2014 | 653 | 0.080 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 27 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2009 | 69 | 0.080 |
Why?
|
Mutism | 1 | 2008 | 21 | 0.080 |
Why?
|
Smith-Magenis Syndrome | 3 | 2014 | 126 | 0.080 |
Why?
|
14-3-3 Proteins | 1 | 2009 | 143 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 488 | 0.080 |
Why?
|
Skin Pigmentation | 1 | 2008 | 47 | 0.080 |
Why?
|
RNA, Small Nucleolar | 1 | 2008 | 25 | 0.080 |
Why?
|
Heterozygote | 3 | 2020 | 1020 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2012 | 470 | 0.080 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2008 | 142 | 0.080 |
Why?
|
NADPH Oxidases | 1 | 2008 | 146 | 0.080 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2008 | 62 | 0.080 |
Why?
|
Nervous System Malformations | 1 | 2009 | 133 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2013 | 846 | 0.080 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 208 | 0.080 |
Why?
|
Failure to Thrive | 1 | 2008 | 91 | 0.080 |
Why?
|
Eye Proteins | 2 | 2010 | 269 | 0.080 |
Why?
|
Recurrence | 3 | 2014 | 4758 | 0.080 |
Why?
|
Neck | 2 | 2022 | 383 | 0.080 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2007 | 18 | 0.080 |
Why?
|
Infertility, Male | 1 | 2011 | 297 | 0.080 |
Why?
|
Language Disorders | 1 | 2007 | 26 | 0.080 |
Why?
|
High Mobility Group Proteins | 1 | 2007 | 59 | 0.070 |
Why?
|
Antigens, CD | 1 | 2012 | 1385 | 0.070 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2007 | 185 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2011 | 3154 | 0.070 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2009 | 161 | 0.070 |
Why?
|
Middle Aged | 13 | 2015 | 86204 | 0.070 |
Why?
|
Disorders of Sex Development | 1 | 2007 | 88 | 0.070 |
Why?
|
Speech Disorders | 1 | 2007 | 91 | 0.070 |
Why?
|
Mitosis | 1 | 1989 | 615 | 0.070 |
Why?
|
Angelman Syndrome | 2 | 2017 | 78 | 0.070 |
Why?
|
Decidua | 1 | 1987 | 154 | 0.070 |
Why?
|
Heterochromatin | 1 | 2006 | 83 | 0.070 |
Why?
|
Trisomy 13 Syndrome | 2 | 2017 | 18 | 0.070 |
Why?
|
Trisomy 18 Syndrome | 2 | 2017 | 15 | 0.070 |
Why?
|
Gene Silencing | 1 | 2009 | 837 | 0.070 |
Why?
|
Karyotype | 2 | 2016 | 234 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 1 | 2007 | 365 | 0.070 |
Why?
|
GTPase-Activating Proteins | 2 | 2018 | 126 | 0.070 |
Why?
|
Fertilization in Vitro | 1 | 2007 | 199 | 0.070 |
Why?
|
Mice | 11 | 2017 | 34495 | 0.070 |
Why?
|
Uterus | 1 | 2010 | 678 | 0.070 |
Why?
|
Embryo Transfer | 1 | 2006 | 83 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3230 | 0.070 |
Why?
|
Sex Chromosome Disorders of Sex Development | 2 | 2017 | 10 | 0.060 |
Why?
|
Sequence Alignment | 3 | 2013 | 844 | 0.060 |
Why?
|
Computational Biology | 1 | 2011 | 1271 | 0.060 |
Why?
|
Endopeptidases | 1 | 2006 | 220 | 0.060 |
Why?
|
WT1 Proteins | 1 | 2005 | 106 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2008 | 479 | 0.060 |
Why?
|
Fathers | 2 | 2007 | 68 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2006 | 354 | 0.060 |
Why?
|
Klebsiella Infections | 1 | 2004 | 64 | 0.060 |
Why?
|
Siblings | 2 | 2018 | 285 | 0.060 |
Why?
|
Mitochondria | 1 | 2011 | 1282 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2014 | 4143 | 0.060 |
Why?
|
Bone and Bones | 1 | 2007 | 619 | 0.060 |
Why?
|
DNA Mutational Analysis | 4 | 2010 | 2283 | 0.060 |
Why?
|
Radiography | 3 | 2015 | 1904 | 0.060 |
Why?
|
Lymphocytes | 3 | 2015 | 1234 | 0.060 |
Why?
|
Thrombocytopenia | 1 | 2008 | 846 | 0.060 |
Why?
|
CpG Islands | 2 | 2016 | 633 | 0.050 |
Why?
|
Algorithms | 1 | 2013 | 3890 | 0.050 |
Why?
|
Auditory Threshold | 1 | 2001 | 26 | 0.050 |
Why?
|
Megalencephaly | 2 | 2012 | 56 | 0.050 |
Why?
|
Pilot Projects | 1 | 2008 | 2803 | 0.050 |
Why?
|
Biopsy | 2 | 2006 | 3443 | 0.050 |
Why?
|
Cats | 1 | 2001 | 166 | 0.050 |
Why?
|
HIV Infections | 1 | 2014 | 2134 | 0.050 |
Why?
|
Acoustic Stimulation | 1 | 2001 | 118 | 0.050 |
Why?
|
DNA Breaks | 2 | 2012 | 39 | 0.050 |
Why?
|
Electrophysiology | 1 | 2001 | 333 | 0.050 |
Why?
|
Reaction Time | 1 | 2001 | 234 | 0.050 |
Why?
|
Menotropins | 1 | 2000 | 7 | 0.050 |
Why?
|
Mesencephalon | 1 | 1999 | 58 | 0.040 |
Why?
|
Ovulation Induction | 1 | 2000 | 62 | 0.040 |
Why?
|
Globus Pallidus | 1 | 1999 | 71 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 78 | 0.040 |
Why?
|
Hypotrichosis | 1 | 2018 | 5 | 0.040 |
Why?
|
Foot Deformities, Congenital | 1 | 2018 | 15 | 0.040 |
Why?
|
Embryo, Mammalian | 2 | 2015 | 741 | 0.040 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2018 | 13 | 0.040 |
Why?
|
Genetic Background | 1 | 2018 | 8 | 0.040 |
Why?
|
Ultrasonography | 1 | 1985 | 1863 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2010 | 1870 | 0.040 |
Why?
|
Prognosis | 4 | 2019 | 21713 | 0.040 |
Why?
|
Pregnancy, High-Risk | 2 | 1988 | 49 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 203 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2015 | 6100 | 0.040 |
Why?
|
Micrognathism | 1 | 2018 | 66 | 0.040 |
Why?
|
Patched Receptors | 2 | 2008 | 46 | 0.040 |
Why?
|
SMARCB1 Protein | 1 | 2018 | 109 | 0.040 |
Why?
|
Patched-1 Receptor | 2 | 2008 | 48 | 0.040 |
Why?
|
Haplotypes | 1 | 2020 | 856 | 0.040 |
Why?
|
Cri-du-Chat Syndrome | 1 | 2017 | 4 | 0.040 |
Why?
|
Chromosome Painting | 2 | 2008 | 24 | 0.040 |
Why?
|
Klinefelter Syndrome | 1 | 2017 | 23 | 0.040 |
Why?
|
Family Health | 2 | 2010 | 325 | 0.040 |
Why?
|
Human Genome Project | 1 | 2017 | 64 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2009 | 354 | 0.040 |
Why?
|
Epigenomics | 1 | 2018 | 266 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 318 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 1999 | 383 | 0.040 |
Why?
|
Choanal Atresia | 1 | 2016 | 16 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 287 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 4892 | 0.030 |
Why?
|
DNA Helicases | 1 | 2018 | 434 | 0.030 |
Why?
|
Pregnancy, Twin | 1 | 2016 | 118 | 0.030 |
Why?
|
Gene Expression | 2 | 2015 | 3570 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 3639 | 0.030 |
Why?
|
Cerebellum | 1 | 1999 | 449 | 0.030 |
Why?
|
Problem Behavior | 1 | 2015 | 36 | 0.030 |
Why?
|
Asialoglycoprotein Receptor | 1 | 2014 | 4 | 0.030 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 575 | 0.030 |
Why?
|
Polyadenylation | 1 | 2015 | 70 | 0.030 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2014 | 18 | 0.030 |
Why?
|
Minisatellite Repeats | 1 | 2014 | 51 | 0.030 |
Why?
|
Dishevelled Proteins | 1 | 2014 | 59 | 0.030 |
Why?
|
Genitalia | 1 | 2014 | 46 | 0.030 |
Why?
|
Embryo, Nonmammalian | 1 | 2015 | 234 | 0.030 |
Why?
|
Aortography | 1 | 2015 | 181 | 0.030 |
Why?
|
Ciprofloxacin | 1 | 1995 | 89 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2015 | 148 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 2488 | 0.030 |
Why?
|
Sex Factors | 1 | 2019 | 2139 | 0.030 |
Why?
|
Cytochrome P-450 CYP2B6 | 1 | 2014 | 22 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 1999 | 1945 | 0.030 |
Why?
|
Hong Kong | 1 | 2014 | 71 | 0.030 |
Why?
|
Alkynes | 1 | 2014 | 29 | 0.030 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2013 | 16 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 4744 | 0.030 |
Why?
|
Genes, Duplicate | 1 | 2013 | 21 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2015 | 406 | 0.030 |
Why?
|
Hyperkinesis | 1 | 2013 | 23 | 0.030 |
Why?
|
Lithium | 1 | 2013 | 71 | 0.030 |
Why?
|
Inhibitory Postsynaptic Potentials | 1 | 2013 | 48 | 0.030 |
Why?
|
Genome | 1 | 2017 | 672 | 0.030 |
Why?
|
Neoplasms | 2 | 2011 | 15193 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2014 | 88 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2013 | 69 | 0.030 |
Why?
|
Obesity | 1 | 2006 | 2884 | 0.030 |
Why?
|
Base Composition | 1 | 2013 | 92 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2010 | 4233 | 0.030 |
Why?
|
Nucleotide Motifs | 1 | 2013 | 62 | 0.030 |
Why?
|
Cell Division | 2 | 2014 | 2489 | 0.030 |
Why?
|
Y Chromosome | 2 | 1991 | 77 | 0.030 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 1995 | 193 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 651 | 0.030 |
Why?
|
Neurodevelopmental Disorders | 1 | 2017 | 413 | 0.030 |
Why?
|
Endoglin | 1 | 2012 | 43 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 14889 | 0.030 |
Why?
|
Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 24 | 0.030 |
Why?
|
Xenopus laevis | 1 | 2013 | 270 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2013 | 245 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2013 | 331 | 0.030 |
Why?
|
Cognition | 1 | 2018 | 968 | 0.030 |
Why?
|
Valproic Acid | 1 | 2013 | 263 | 0.030 |
Why?
|
Dwarfism | 1 | 2013 | 109 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 2012 | 130 | 0.030 |
Why?
|
Abnormal Karyotype | 1 | 2012 | 100 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 1995 | 318 | 0.030 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1995 | 247 | 0.030 |
Why?
|
Nerve Net | 1 | 2015 | 257 | 0.030 |
Why?
|
Ofloxacin | 1 | 1991 | 41 | 0.030 |
Why?
|
Eye Abnormalities | 1 | 2012 | 118 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 621 | 0.030 |
Why?
|
Diaphragmatic Eventration | 1 | 2011 | 8 | 0.030 |
Why?
|
Protein Interaction Maps | 1 | 2012 | 149 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2014 | 575 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 9 | 0.020 |
Why?
|
Fertility | 1 | 2014 | 336 | 0.020 |
Why?
|
Short Stature Homeobox Protein | 1 | 2011 | 11 | 0.020 |
Why?
|
Biological Evolution | 1 | 2012 | 278 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 74 | 0.020 |
Why?
|
NAV1.3 Voltage-Gated Sodium Channel | 1 | 2010 | 3 | 0.020 |
Why?
|
NAV1.2 Voltage-Gated Sodium Channel | 1 | 2010 | 5 | 0.020 |
Why?
|
Body Dysmorphic Disorders | 1 | 2011 | 31 | 0.020 |
Why?
|
Risk Factors | 3 | 2016 | 17523 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2011 | 220 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2010 | 59 | 0.020 |
Why?
|
Actins | 1 | 2013 | 608 | 0.020 |
Why?
|
MEF2 Transcription Factors | 1 | 2010 | 47 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 664 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2010 | 78 | 0.020 |
Why?
|
Hypotension, Orthostatic | 1 | 2010 | 21 | 0.020 |
Why?
|
Bladder Exstrophy | 1 | 2010 | 11 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1077 | 0.020 |
Why?
|
Limb Deformities, Congenital | 1 | 2011 | 112 | 0.020 |
Why?
|
Coloboma | 1 | 2010 | 43 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 709 | 0.020 |
Why?
|
Genes, Wilms Tumor | 1 | 2010 | 64 | 0.020 |
Why?
|
Anal Canal | 1 | 2011 | 238 | 0.020 |
Why?
|
Risk | 1 | 2014 | 1972 | 0.020 |
Why?
|
Spermatozoa | 1 | 2012 | 315 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2011 | 233 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2013 | 745 | 0.020 |
Why?
|
Pleural Effusion | 1 | 1991 | 201 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 1999 | 4314 | 0.020 |
Why?
|
Chromatin | 1 | 2015 | 942 | 0.020 |
Why?
|
GATA4 Transcription Factor | 1 | 2009 | 45 | 0.020 |
Why?
|
Inverted Repeat Sequences | 1 | 2009 | 13 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 1152 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 701 | 0.020 |
Why?
|
Templates, Genetic | 1 | 2009 | 86 | 0.020 |
Why?
|
Physical Chromosome Mapping | 1 | 2009 | 73 | 0.020 |
Why?
|
SOXB1 Transcription Factors | 1 | 2010 | 123 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 644 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 86 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 99 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2013 | 785 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.020 |
Why?
|
Sister Chromatid Exchange | 1 | 2008 | 45 | 0.020 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2008 | 38 | 0.020 |
Why?
|
Trachea | 1 | 2011 | 259 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2014 | 1152 | 0.020 |
Why?
|
Hippocampus | 1 | 2015 | 915 | 0.020 |
Why?
|
snRNP Core Proteins | 1 | 2008 | 9 | 0.020 |
Why?
|
Ectodysplasins | 1 | 2008 | 7 | 0.020 |
Why?
|
Serrate-Jagged Proteins | 1 | 2008 | 85 | 0.020 |
Why?
|
Hair Color | 1 | 2008 | 20 | 0.020 |
Why?
|
Pulmonary Surfactants | 1 | 2008 | 50 | 0.020 |
Why?
|
CD11b Antigen | 1 | 2008 | 66 | 0.020 |
Why?
|
Culture Media | 1 | 1989 | 319 | 0.020 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2008 | 43 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2014 | 878 | 0.020 |
Why?
|
Jagged-1 Protein | 1 | 2008 | 101 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2008 | 6915 | 0.020 |
Why?
|
Alagille Syndrome | 1 | 2008 | 44 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2008 | 74 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2014 | 3033 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2013 | 7222 | 0.020 |
Why?
|
Hirsutism | 1 | 2007 | 18 | 0.020 |
Why?
|
Reference Standards | 1 | 2009 | 339 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 1988 | 168 | 0.020 |
Why?
|
Color | 1 | 2008 | 66 | 0.020 |
Why?
|
Megakaryocytes | 1 | 2008 | 104 | 0.020 |
Why?
|
Aged | 3 | 2012 | 70117 | 0.020 |
Why?
|
Psychological Tests | 1 | 2008 | 131 | 0.020 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 1 | 2007 | 10 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1988 | 205 | 0.020 |
Why?
|
Esophagus | 1 | 2011 | 553 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 2009 | 174 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 1991 | 426 | 0.020 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2007 | 53 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2009 | 829 | 0.020 |
Why?
|
Allelic Imbalance | 1 | 2007 | 41 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 408 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 4053 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 1988 | 112 | 0.020 |
Why?
|
Autoantigens | 1 | 2008 | 234 | 0.020 |
Why?
|
Biomarkers | 1 | 2018 | 5047 | 0.020 |
Why?
|
Clone Cells | 1 | 2008 | 555 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2008 | 217 | 0.020 |
Why?
|
Terminal Repeat Sequences | 1 | 2006 | 27 | 0.020 |
Why?
|
Prospective Studies | 2 | 2014 | 12873 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 274 | 0.020 |
Why?
|
Rett Syndrome | 1 | 2009 | 262 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2008 | 1213 | 0.020 |
Why?
|
Bisbenzimidazole | 1 | 1985 | 6 | 0.020 |
Why?
|
Azure Stains | 1 | 1985 | 11 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 650 | 0.020 |
Why?
|
Schizophrenia | 1 | 2008 | 369 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 1985 | 139 | 0.020 |
Why?
|
Tuberculosis | 1 | 1991 | 548 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 1099 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 602 | 0.020 |
Why?
|
Monocytes | 1 | 2008 | 788 | 0.020 |
Why?
|
Neurons | 1 | 2015 | 2287 | 0.020 |
Why?
|
RNA, Long Noncoding | 1 | 2009 | 598 | 0.010 |
Why?
|
Glycoproteins | 1 | 2007 | 747 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 7548 | 0.010 |
Why?
|
Aging | 1 | 2012 | 1582 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 2292 | 0.010 |
Why?
|
Trophoblasts | 1 | 1983 | 138 | 0.010 |
Why?
|
Electrocardiography | 1 | 2008 | 1145 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 2450 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1999 | 4849 | 0.010 |
Why?
|
Doxorubicin | 1 | 2009 | 3005 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 2146 | 0.010 |
Why?
|
Gestational Age | 1 | 1985 | 1069 | 0.010 |
Why?
|
Fibroblasts | 1 | 1988 | 1682 | 0.010 |
Why?
|
Texas | 1 | 2012 | 6311 | 0.010 |
Why?
|
Binomial Distribution | 1 | 1999 | 6 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 7551 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 1287 | 0.010 |
Why?
|
Echocardiography | 1 | 2004 | 1182 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1988 | 3719 | 0.010 |
Why?
|
Cholesterol Esters | 1 | 1976 | 34 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1999 | 1323 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 12926 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1995 | 425 | 0.010 |
Why?
|
Probability | 1 | 1994 | 866 | 0.010 |
Why?
|
Cholesterol | 1 | 1976 | 658 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 217 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 14551 | 0.010 |
Why?
|
Signal Transduction | 1 | 2008 | 11965 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1991 | 548 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1995 | 2315 | 0.010 |
Why?
|
Sex Determination Analysis | 1 | 1983 | 20 | 0.000 |
Why?
|
Cytological Techniques | 1 | 1983 | 74 | 0.000 |
Why?
|
Cytodiagnosis | 1 | 1983 | 220 | 0.000 |
Why?
|
In Vitro Techniques | 1 | 1983 | 1618 | 0.000 |
Why?
|
Placenta | 1 | 1983 | 516 | 0.000 |
Why?
|
Twins, Dizygotic | 1 | 1976 | 49 | 0.000 |
Why?
|
Lipoproteins, VLDL | 1 | 1976 | 89 | 0.000 |
Why?
|
Lipoproteins, LDL | 1 | 1976 | 163 | 0.000 |
Why?
|
Twins, Monozygotic | 1 | 1976 | 129 | 0.000 |
Why?
|
Lipoproteins, HDL | 1 | 1976 | 144 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1995 | 29902 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1976 | 2307 | 0.000 |
Why?
|